HOOKIPA Pharma Inc. (NASDAQ:HOOK)
Industry: Consumer Goods

OFF LIST - 2424 consecutive market days: OFF LIST as of 10/18/2006 Through 11/14/2016

HOOKIPA Pharma Inc., a clinical-stage biopharmaceutical company, develops immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform. The company's lead infectious disease product candidate is HB-101, which is in a randomized double-blinded Phase 2 clinical trial in cytomegalovirus-negative patients awaiting kidney transplantation from cytomegalovirus-positive donors. Its lead oncology product candidates are HB-201 and HB-202 that are in preclinical studies for the treatment of human papillomavirus-positive cancers. The company has a collaboration with Gilead Sciences, Inc. to develop arenavirus based therapeutics to treat hepatitis B virus and human immunodeficiency virus infections. HOOKIPA Pharma Inc. was founded in 2011 and is headquartered in New York, New York.

Current Quote*
Last: $8.800
Change: -0.870
Book: $Unk
Volume: 9,128

As Of: 06/14 13:19 ET
*Quotes delayed by 20min.

Graphs for HOOK


3 Month Graph


6 Month Graph


1 Year Graph